Cancer Transcriptomics: Integrative & Computational Approaches
Oncogenomics is a relatively new sub-field of genomics that applies high throughput technologies to characterize genes associated with cancer. The study involves the research in to the Bioinformatics and functional analysis of oncogenes, which refers to the gene that has the potential to cause cancer. In tumor cells, they are often mutated or expressed at high levels.
Cancer genome sequencing requires the development of new techniques utilizing Genomics and bioinformatics tools for target assessment, including both experimental protocols and data analysis algorithms, to enable a deeper understanding of complex biological systems. Databases for Cancer Research have been developed which primarily study the Mutations in Mitochondrial DNA and Cancer to come up with effective and informative databases. It involves the development of Tools for integrative meta-analysis, 3c-based data integration and application of Networks and OMICS data, mathematical modeling and computational simulation techniques to the study of Integrative eqtl-based analyses, High performance genomics data visualization and Laboratory information management system to come up with Potential Diagnostic Applications.
Computational Genomics research has grown after the increased research in Genomics with major universities like Iowa State University, University Of California, and The George Washington University Concentrating on the growing topic. The Bisti Consortium has even launched the NIH and Government Programs and Initiatives in Biomedical Informatics and Computational Biology (BICB) with a list of programs concentrating on Computational Biology Research.
Cancer Diagnostics Conference & Expo June 13-15, 2016 Rome, Italy; 11th Asia-Pacific Oncologists Annual Meeting July 11-13, 2016 Kuala Lumpur, Malaysia; 12th Cancer Therapy Euro Summit September 26-28, 2016 London, UK; Pancreatic and Colorectal Cancer Conference March 29-30, 2016, Atlanta, USA; Prostate Cancer and Treatment Conference May 05-07, 2016, Chicago, USA; Advances in Breast Cancer Research, Bellevue, October 17 - 20, 2015, Washington USA; AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics, November 5-9, 2015 Boston, USA; New Horizons in Cancer Research Conference: Bringing Cancer Discoveries to Patients, November 12-15, 2015, Shanghai, P.R. China; IMPAKT 2016 Breast Cancer Conference, Brussels, May 12-14, 2016, Brussels, Belgium; 10th European Breast Cancer Conference March 09-11, 2016, Amsterdam, The Netherlands.
The overall mission of Oncogenomics is to leverage the power of genome wide high-throughput approaches to improve the outcome of patients with high risk cancers. A genomic era of cancer studies is developing rapidly, fueled by the emergence of next-generation sequencing technologies that provide exquisite sensitivity and resolution. Integrative analyses that evaluate cancer transcriptome data in the context of other data sources are often capable of extracting deeper biological insight from the data. Comparative oncogenomics identifies breast tumors enriched in functional tumor-initiating cells and several other types of oncogenic cells. Somatic mitochondrial DNA (mtDNA) mutations have been increasingly observed in primary human cancers. As each cell contains many mitochondria with multiple copies of mtDNA, it is possible that wild-type and mutant mtDNA can co-exist in a state called heteroplasmy. A cancer biomarker refers to a substance or process that is indicative of the presence of cancer in the body.
- Introduction to Oncogenomics
- Cancer genome sequencing
- Cancer Transcriptomes
- Bioinformatics and functional analysis of oncogenes
- Comparative Oncogenomics
- Databases for Cancer Research
- Advances from Oncogenomics
- Mutations in Mitochondrial DNA and Cancer
- Potential Diagnostic Applications
- Cancer Biomarkers
- P53 mediated Transcriptomics
Related Conference of Cancer Transcriptomics: Integrative & Computational Approaches
Cancer Transcriptomics: Integrative & Computational Approaches Conference Speakers
- Cancer Transcriptomics: Integrative & Computational Approaches
- Clinical Applications & Related Disorders
- Diagnosis & Applications of RNA-Seq
- Exploring Transcriptome
- Expression Profiling
- Human Transcriptomics
- NGS Technologies
- Ocular Transcriptomics
- Relation with OMICS Sciences
- RNA Editing & Interference: Interplay
- Single Cell Transcriptomics
- Transcriptional Regulation & Attenuation
- Transcriptome analysis & Gene Expression
- Transcriptome Technologies Market
- Transcriptomics & Proteomics in Microorganisms
- Transcriptomics & Proteomics in Plants
- Transcriptomics and Mass Spectrometry
- Transcriptomics Case Reports